Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07591701 · ClinicalTrials.gov registry record · NA

Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

A NA study, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
60
Enrollment target

NCT07591701: Recruiting NA study, sponsored by M.D. Anderson Cancer Center.

NCT07591701 is a NA study that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07591701, a NA study, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percentage of participants from these backgrounds on cancer clinical trials.

Interventions

  • OTHER Video

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-05-26
Est. Completion 2030-01-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT07591701

The ClinicalTrials.gov registry entry for NCT07591701 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Video is the first listed.

NCT07591701 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07591701 about?

NCT07591701 is a clinical study titled "Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital". The main rationale underlying this study is that prostate cancer clinical trials are lacking representation from racial and ethnic minority groups. Study proposal aims to target barriers at the participant, investigator, and health system level through specific interventions to increase the percenta...

What is the current status of trial NCT07591701?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-05-26. Estimated completion is 2030-01-31.

What interventions are being tested in trial NCT07591701?

The interventions under investigation include: Video (OTHER).

Who is sponsoring clinical trial NCT07591701?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.